MedTrace Logo

Trial Comparing BST-CarGel and Microfracture in Repair of Articular Cartilage Lesions in the Knee

NCT00314236 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2015-12-18

Study results available
· View outcomes & findings →

Summary

This study will investigate whether the treatment of damaged cartilage in the knee with BST-CarGel will increase the amount and quality of cartilage repair tissue when compared with microfracture alone. Furthermore, the effect of BST-CarGel in decreasing cartilage related pain and improving cartilage-related function in the knee will be assessed.

Conditions

  • Knee Injuries

Interventions

DEVICE

BST-CarGel with Microfracture

Microfracture performed with BST-CarGel added to the treated defect

PROCEDURE

Microfracture without BST-CarGel

Microfracture performed without BST-CarGel added to the treated defect.

Sponsors & Collaborators

  • Piramal Healthcare Canada Ltd

    lead INDUSTRY

Principal Investigators

  • William Stanish, MD · Orthopaedic and Sport Medicine - Dalhousie University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2011-02-28
Completion
2011-05-31

Countries

  • Canada
  • South Korea
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00314236 on ClinicalTrials.gov